Trilostane, an orally active inhibitor of steroid biosynthesis

@article{Potts1978TrilostaneAO,
  title={Trilostane, an orally active inhibitor of steroid biosynthesis},
  author={Gordon O. Potts and John E. Creange and Homer R. Harding and H. Philip Schane},
  journal={Steroids},
  year={1978},
  volume={32},
  pages={257-267}
}
Trilostane is a competitive inhibitor of 3beta-hydroxysteroid dehydrogenase. In vitro, the drug inhibits conversion of pregnenolone to progesterone but does not alter conversion of cholesterol to pregnenolone nor progesterone to corticoid hormones. When given orally to rats, trilostane inhibits corticosterone and aldosterone production and elevates circulating levels of pregnenolone at doses lower than those that produce adrenal hypertrophy or inhibit gonadal steroidogenesis. 
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 64 CITATIONS

Treatment of Cushing's disease: a mechanistic update.

  • The Journal of endocrinology
  • 2014
VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

1982
2018

CITATION STATISTICS

  • 9 Highly Influenced Citations

  • Averaged 3 Citations per year over the last 3 years

Similar Papers

Loading similar papers…